Dr. Steven H. Lin, MD
Claim this profileM D Anderson Cancer Center
Studies Esophageal Cancer
Studies Lung Cancer
7 reported clinical trials
17 drugs studied
Area of expertise
1Esophageal Cancer
Stage III
Stage II
2Lung Cancer
Stage III
Stage II
PD-L1 positive
Affiliated Hospitals
Clinical Trials Steven H. Lin, MD is currently running
NBTXR3 + Chemoradiation
for Esophageal Cancer
The purpose of this Phase I study is to determine the recommended phase 2 dose (RP2D) and safety profile of NBTXR3 activated by radiation therapy with concurrent chemotherapy for the treatment of patients with esophageal adenocarcinoma. NBTXR3 is a drug that when activated by radiation therapy, may cause targeted destruction of cancer cells. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. Chemotherapy drugs, such as oxaliplatin, fluorouracil, capecitabine, docetaxel, paclitaxel, and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving NBTXR3 activated by radiation therapy with concurrent chemotherapy may help control the disease.
Recruiting3 awards Phase 1
NKTR-255 + Durvalumab
for Lung Cancer
This trial is testing NKTR-255 and durvalumab in patients with advanced lung cancer who have had previous treatment. The goal is to boost their immune system to better fight the cancer. Durvalumab has shown survival benefits for patients after their initial treatment.
Recruiting1 award Phase 2
More about Steven H. Lin, MD
Clinical Trial Related5 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Steven H. Lin, MD has experience with
- Durvalumab
- Carboplatin
- Paclitaxel
- Radiation Therapy
- NKTR-255
- Capecitabine
Breakdown of trials Steven H. Lin, MD has run
Esophageal Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Stomach Cancer
Esophageal Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Steven H. Lin, MD specialize in?
Steven H. Lin, MD focuses on Esophageal Cancer and Lung Cancer. In particular, much of their work with Esophageal Cancer has involved Stage III patients, or patients who are Stage II.
Is Steven H. Lin, MD currently recruiting for clinical trials?
Yes, Steven H. Lin, MD is currently recruiting for 3 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Steven H. Lin, MD has studied deeply?
Yes, Steven H. Lin, MD has studied treatments such as Durvalumab, Carboplatin, Paclitaxel.
What is the best way to schedule an appointment with Steven H. Lin, MD?
Apply for one of the trials that Steven H. Lin, MD is conducting.
What is the office address of Steven H. Lin, MD?
The office of Steven H. Lin, MD is located at: M D Anderson Cancer Center, Houston, Texas 77030 United States. This is the address for their practice at the M D Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.